| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.4 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |